Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study) - Sheng - 2020 - Clinical
Doctors at Cleveland Clinic Hillcrest Hospital in Cleveland, OH | US News Best Hospitals Rankings
Robier Aguillon-Prada's research works | University of Miami Miller School of Medicine, Florida (UM) and other places
Robier Aguillon-Prada's research works | University of Miami Miller School of Medicine, Florida (UM) and other places